OPTIMA

Optimal Personalised Treatment of breast cancer using Multiparameter Analysis 🧬 This account is aimed at NHS Staff.

[Iain Macpherson @IR_Macpherson]

Very exciting time for everyone involved. Looking forward to much discussion of the results and hopefully rapid implementation for real patient benefit

[OPTIMA @OPTIMAbstudy]

The latest #OPTIMA newsletter can now be found on our website 👇

https://t.co/UM9H4ij31L

[OPTIMA @OPTIMAbstudy]

#RecruitmentUpdate 🦩☀️

Although UK recruitment has stopped, international Sites continue to recruit into OPTIMA-Main.

Norway, Australia and Thailand all recruited participants in August. Thank you to all Sites for their ongoing efforts!

[OPTIMA @OPTIMAbstudy]

#RecruitmentUpdate #HelloAugust 🌷

Although UK recruitment has stopped, international Sites continue to recruit into OPTIMA-Main.

#Thankyou to all of our trials teams and patients throughout the world, who continue to make the OPTIMA study possible.

[OPTIMA @OPTIMAbstudy]

The most recent OPTIMA Newsletter is now available on our website 👇

https://t.co/xh3RUzrTGm

[OPTIMA @OPTIMAbstudy]

"Path-for-young is centred around a global, pragmatic randomized controlled trial that is focused on de-escalating chemotherapy among premenopausal patients with high-risk HR+HER2- breast cancer: the Optima-young clinical trial"

#Watchthisspace #OPTIMAyoung #PathForYoung

[PathforYoung @PathforYoung]

🚀 The #PathforYoung website is now live! This EU-funded study unites 20+ partners to improve care for young women with hormone-dependent breast cancer at high risk of recurrence. Discover goals, partners, patient role & news 🔗 https://t.co/3cv3NNPovC #EU4Health #HorizonEU

[Warwick CTU @WarwickCTU]

To celebrate NHS, Social Care, and Frontline Workers’ Day tomorrow, we want to say a huge THANK YOU to all the incredible NHS, social care, and frontline staff who support our studies.

Without you, our research wouldn’t be possible, and we are grateful for everything you do.✨

[OPTIMA @OPTIMAbstudy]

#RecruitmentUpdate #HelloJuly 🌷

Although UK recruitment has stopped, international Sites continue to recruit into OPTIMA-Main.

#Thankyou to all of our trials teams and patients throughout the world, who continue to make the OPTIMA study possible.

[OPTIMA @OPTIMAbstudy]

🎉🌟5⃣0⃣0⃣🌟🎉

500 participants have now joined the trial across Norway and Sweden!

The first Norwegian Site opened in 2018 and the team at Oslo University Hospital have now recruited over 170 patients in total. Amazing work from everyone involved.

@Oslounivsykehus

[OPTIMA @OPTIMAbstudy]

Happy #RED4RESEARCH day ❤️

Red4Research brings together all those participating, supporting, and undertaking research. On the front line and behind the scenes, incredible research teams collectively work together to make studies like OPTIMA happen.

#Thankyou to all involved.

[OPTIMA @OPTIMAbstudy]

🎉🌟2⃣0⃣0⃣🌟🎉

200 participants have now joined the trial across Australia and New Zealand! Amazing work from everyone involved.

The first Australian Site opened in January 2024 and there are now 48 Sites recruiting throughout Australia and New Zealand.

@BCTrialsANZ

[OPTIMA @OPTIMAbstudy]

#RecruitmentUpdate #HappyJune 🌷

We're now less than 150 participants away from reaching our final recruitment target 🌟

#Thankyou to all of our hardworking trials teams and pioneering patients throughout the world, who make the OPTIMA study possible.

[OPTIMA @OPTIMAbstudy]

The most recent OPTIMA Newsletter is now available on our website!

In this edition:
📍recruitment updates
📍OPTIMA prelim results
📍Follow up top tips
...and more!

https://t.co/xh8kubecco

#OPTIMANewsletter

[Veracyte, Inc. @Veracyte]

Today at #ESMOBreast25: 10-year OPTIMA PRELIM clinical outcomes presented. Findings show #Prosigna breast cancer assay better classified patients' risk of recurrence as compared to the test used to initially assign patients to treatment groups. Results from this early feasibility study contributed to Prosigna's selection for the ongoing 4500-patient prospective OPTIMA trial.

View Presentation: https://t.co/Zgcg9SH3PO

Important Note: https://t.co/tltSRBtiSL

[OPTIMA @OPTIMAbstudy]

On Thursday 15th May 2025, Prof Rob Stein presented the OPTIMA-prelim 10-year follow up results at the ESMO Breast Cancer Conference.

You can find a copy of the slides on the OPTIMA Website (link below)

https://t.co/oDcLmPzzkv

#OPTIMAprelim #BreastCancerTrials #ESMOBreast25

[NHS England @NHSEngland]

Happy International Nurses’ Day!

Thank you to all our amazing nurses for the care and support you provide to patients every day. 💙

With more than 50 different nursing roles in the NHS, no two nursing careers are the same.

Learn more: https://t.co/G4mKhtOOzs

#IND2025

[OPTIMA @OPTIMAbstudy]

@WarwickCTU We're looking forward to sharing the results!

[Warwick CTU @WarwickCTU]

Prof Stein is presenting the OPTIMA Prelim results (10 year follow up) at the ESMO Breast Conference in Munich next week!

Join him in Room 14 on Thursday 15th May, from 2pm, if you can!

More information can be found here: https://t.co/ZVwICG16tj

@OPTIMAbstudy #ESMOBreast25

[OPTIMA @OPTIMAbstudy]

#RecruitmentUpdate 🪻💙

#Thankyou to all of our hardworking trials teams and patients throughout the world, who make the OPTIMA study possible.

#itsgunabemay #HappyMay

[OPTIMA @OPTIMAbstudy]

‼️ We want to hear from you ‼️

Please complete the short survey via the link below. We're extremely grateful for your feedback!

https://t.co/eMm8yCuOpW